UFF
AMPH icon

USA Financial Formulas’s Amphastar Pharmaceuticals AMPH Stock Holding History

USA Financial Formulas’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9
Closed -$414 – 352
2023
Q3 		$414 Buy
+9
New +$491 ﹤0.01% 461
2022
Q3 		$33K Sell
1,181
-1,334
-53% -$43.6K 0.05% 88
2022
Q2 		$87K Sell
2,515
-900
-26% -$32.1K 0.11% 103
2022
Q1 		$123K Buy
+3,415
New +$96.8K 0.13% 78

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

USA Financial Formulas's AMPH Position: Q4 2023 in Review

USA Financial Formulas sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2023, closing a stake of 9 shares — an estimated $414 sold.

USA Financial Formulas first reported a position in AMPH in Q1 2022 and held it in 4 quarters. The position peaked at $123K in Q1 2022. 276 funds tracked by Wall St. Rank hold AMPH as of Q4 2023.

  • USA Financial Formulas reported no remaining Amphastar Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • USA Financial Formulas sold 9 Amphastar Pharmaceuticals shares in Q4 2023, an estimated $414.
  • USA Financial Formulas first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • USA Financial Formulas's Amphastar Pharmaceuticals position peaked at $123K in Q1 2022.
  • 276 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2023.

Based on USA Financial Formulas's 13F filing for Q4 2023, filed 7 Feb 2024.